Hemodynamic effects of nitric oxide synthase inhibition at steady state and following tumor necrosis factor-α-induced myodepression

Cardiovascular Research

Volumn 44, Issue 3, 1999, Pages 527-535

  Murray, David R ^a   Prabhu, Sumanth D ^a   Freeman, Gregory L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin; Cytokines; Hemodynamics; Nitric oxide; Ventricular function

Indexed keywords

ANGIOTENSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; ENZYME INHIBITION; FEMALE; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE PRESSURE; HEART STROKE VOLUME; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HEART WORK; HEMODYNAMICS; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; STEADY STATE;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DOGS; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR PRESSURE;

EID: 0033454032     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00226-6     Document Type: Article

References (36)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
2. Petros A, Lamb G, Leone A et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovas Res 1994;28:3439.
3. Julou-Schaeffer G, Gray GA, Fleming I et al. Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 1990;259:H1038-H1043.
4. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990;87:3629-3632.
5. Szabo C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide mediated hyporeactivity to noradrenaline precedes nitric oxide synthase induction in endotoxic shock. Br J Pharmacol 1993;108:786-792.
6. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-380.
7. Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res 1996;31:847-867.
8. Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995;92:2119-2126.
9. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation 1994;89:2070-2078.
10. Balligand J-L, Kelly RA, Marsden PA et al. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 1993;90:347-351.
11. Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther 1995;272:945-952.
12. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 1996;93(6):1223-1229.
13. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992;105:575-580.
14. Kinugawa K-I, Kohmoto O, Yao A, Serizawa T, Takahashi T. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. Am J Physiol 1997;272(Heart Circ Physiol 41):H35-H47.
15. Yokoyama T, Vaca L, Rossen RD et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993;92:2303-2312.
16. Finkel MS, Oddis CV, Jacob TD et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
17. Murray DR, Freeman GL. Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996;78:154-160.
18. Quezado ZMN, Karzai W, Danner RL et al. Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs. Am J Respir Crit Care Med 1998;157:1397-1405.
19. 2 delivery in septic dogs. Am J Physiol 1995;268(Heart Circ Physiol 37):H2017-H2023.
20. Breslow MJ, Tobin JR, Bredt DS et al. Nitric oxide as a regulator of adrenal blood flow. Am J Physiol 1993;264(Heart Circ Physiol 33):H464-H469.
21. MAX" to pressure-volume relations: a broader view. Circulation 1988;77:1203-1212.
22. Glower DD, Spratt JA, Snow ND et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985;71:994-1009.
23. max-end-diastolic volume relation in closed chest dogs. Circ Res 1985;56:808-815.
24. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983;245:H773-H780.
25. Shibano T, Vanhoutte PM. Induction of NO production by TNF and lipopolysaccharide in porcine coronary arteries without endothelium. Am J Physiol 1993;264:H403-H407.
26. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265(Heart Circ Physiol 34):H176-H182.
27. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-H1966.
28. Freeman GL, Little WC, O'Rourke RA. The effect of vasoactive agents on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. Circulation 1986;74:1107-1113.
29. Cheng C-P, Suzuki M, Ohte N et al. Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure. Circ Res 1996;78:880-892.
30. Prabhu SD, Rozek MM, Murray DR, Freeman GL. Ryanodine and left ventricular function in intact dogs: dissociation of force-based and velocity-based indexes. Am J Physiol 1997;273(Heart Circ Physiol 42):H1561-H1568.
31. Klabunde RE, Coston AF. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 1995;3:73-78.
32. Meng X-L, Brown JM, Fullerton DA, Banerjee A, Harken AH. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 1997;7:111-118.
33. Michie HR, Manogue KR, Spriggs DR et al. Detection of circulating tumor necrosis factor after endotoxin administration. New Engl J Med 1988;318:1481-1486.
34. Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature (Lond) 1987;330:662-664.
35. Little WC, Cheng CP, Peterson T, Vinten-Johansen J. Response of the left ventricular end-systolic pressure-volume relation in conscious dogs to a wide range of contractile states. Circulation 1988;78:736-745.
36. Smith Jr. TP, Canty JM. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 1993;73:232-240.